2022
Performance Of The MELDXI Score In A Modern Left Ventricular Assist Device Cohort
Stawiarski K, Agboola O, Costantino A, Raskhe A, Bonde R, Bonde P. Performance Of The MELDXI Score In A Modern Left Ventricular Assist Device Cohort. Journal Of Cardiac Failure 2022, 28: s79-s80. DOI: 10.1016/j.cardfail.2022.03.201.Peer-Reviewed Original ResearchPost-operative adverse eventsMELD-XIAdverse eventsHigh riskCox proportional hazard ratiosLeft ventricular assist device placementRed blood cell transfusionVentricular assist device placementMELD-XI scorePerioperative transfusion requirementsPostoperative adverse eventsAdverse perioperative eventsBlood cell transfusionPost-operative bleedingProportional hazard ratiosDisease risk scoreKaplan-Meir plotsWilcoxon rank sum testLog-rank statisticsRank sum testDevice cohortLVAD candidatesTransfusion requirementsBaseline characteristicsCause mortality
2021
Red Cell Distribution Width to Assess Heart Failure Post Left Ventricular Assist Device Implantation
Stawiarski K, Agboola O, Bonde R, Bonde P. Red Cell Distribution Width to Assess Heart Failure Post Left Ventricular Assist Device Implantation. The Journal Of Heart And Lung Transplantation 2021, 40: s436. DOI: 10.1016/j.healun.2021.01.1216.Peer-Reviewed Original ResearchRed cell distribution widthChronic heart failureCell distribution widthCause mortalityImpact of RDWIncreased red cell distribution widthVentricular assist device implantationVentricular assist device therapyDistribution widthPersistent volume overloadAssist device implantationPost-LVAD implantationCox regression modelRed blood cell volumeBone marrow dysfunctionKaplan-Meir plotsBlood cell volumeLack of associationLog-rank statisticsRDW tertilesCox modellingLVAD implantationLVAD placementHeart failureUnadjusted survivalExploring Preoperative Hypocalcemia as a Biomarker for Post Left Ventricular Assist Device Survival and Adverse Events
Stawiarski K, Agboola O, Bonde R, Bonde P. Exploring Preoperative Hypocalcemia as a Biomarker for Post Left Ventricular Assist Device Survival and Adverse Events. The Journal Of Heart And Lung Transplantation 2021, 40: s430. DOI: 10.1016/j.healun.2021.01.1200.Peer-Reviewed Original ResearchAdverse eventsHypocalcemia groupPreoperative hypocalcemiaCause mortalityRight ventricular assist device useLeft ventricular assist device placementChronic heart failure patientsVentricular assist device placementVentricular assist device useDurable LVAD implantationPerioperative renal failureChronic kidney diseaseHeart failure patientsMajority of patientsSerum calcium levelsPoor prognostic markerAbnormal calcium handlingKaplan-Meir plotsLog-rank statisticsCox modellingLVAD implantationLVAD placementPreoperative levelsProlonged intubationRenal failure
2020
Impact of Preoperative Lymphopenia on Survival Following Left Ventricular Assist Device Placement
Stawiarski K, Agboola O, Park J, Geirsson A, Jacoby D, Bellumkonda L, Ahmad T, Chou J, Lee F, Mangi A, Bonde P. Impact of Preoperative Lymphopenia on Survival Following Left Ventricular Assist Device Placement. ASAIO Journal 2020, 67: 650-657. PMID: 33074860, DOI: 10.1097/mat.0000000000001289.Peer-Reviewed Original ResearchConceptsAbsolute lymphocyte countCause mortalityLymphopenia groupLeft ventricular assist device patientsVentricular assist device patientsVentricular assist device placementCox proportional hazards modelImpact of lymphopeniaHeart failure populationKaplan-Meier plotsFurther clinical investigationProportional hazards modelLog-rank statisticsDurable LVADPreoperative lymphopeniaLVAD placementLymphocyte countLymphopenic patientsDevice patientsSingle centerPoor outcomePrognostic implicationsALC levelsFailure populationStudy population
2019
LVAD Survival May Be Predicted by Preoperative Lymphopenia
Stawiarski K, Agboola O, Jacoby D, Bellumkonda L, Sugeng L, Ahmad T, Chen M, McCloskey G, Geirsson A, Anwar M, Bonde P. LVAD Survival May Be Predicted by Preoperative Lymphopenia. The Journal Of Heart And Lung Transplantation 2019, 38: s63-s64. DOI: 10.1016/j.healun.2019.01.142.Peer-Reviewed Original ResearchAbsolute lymphocyte countCause mortalityLVAD patientsImmune modulator therapyImpact of lymphopeniaImportant prognostic indicatorCells/μL.Kaplan-Meir plotsLog-rank statisticsPhysiologic stress responseLVAD survivalPreoperative lymphopeniaSplanchnic congestionCox modellingLymphocyte countLymphocyte levelsLymphopenic patientsUnadjusted survivalWorse survivalHeart failurePrognostic roleSerum sodiumSingle centerPatient groupLVAD therapyChloride Homeostasis in End Stage Heart Failure and LVAD Recipients
Stawiarski K, Agboola O, Jacoby D, Bellumkonda L, Ahmad T, Sugeng L, Chen M, McCloskey G, Geirsson A, Anwar M, Bonde P. Chloride Homeostasis in End Stage Heart Failure and LVAD Recipients. The Journal Of Heart And Lung Transplantation 2019, 38: s382-s383. DOI: 10.1016/j.healun.2019.01.974.Peer-Reviewed Original ResearchSerum chloride levelsChloride homeostasisLVAD patientsHeart failureLVAD therapyEnd-stage heart failureCardio-renal axisChronic heart failureStage heart failureChloride levelsLong-term survivalKaplan-Meir plotsLog-rank statisticsL riseCause mortalityLVAD recipientsWorse survivalSingle centerNeurohormonal responsesPrognostic implicationsPrognostic valueLVAD implantsRetrospective analysisGroup ACox model